CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies

Overview of attention for article published in Clinical Cancer Research, April 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Dimensions has found 36 publications that cite this research output.

Article in Clinical Cancer Research (January 2024)

Article in Frontiers in Immunology (October 2023)

Article in Nature Reviews Drug Discovery (August 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.